Pharmaceutical giant Moderna has promised investors that a coming “next generation” of vaccines is going to reward them with massive profits.
The pledge came following an earnings report which showed the company posted a first-quarter loss of $1.2 billion.
The huge losses are down to dwindling demand for the company’s Covid mRNA injections.
In the first three months of 2024, sales of the company’s Covid shots were a mere $167 million.
During the same period last year, however, Moderna took $2.8 billion in profits from the experimental injections.
In its earnings report, the company said:
“This decline aligns with the anticipated transition to a seasonal COVID-19 vaccine market.
“In the prior year period, the company recognized revenue primarily from delivered doses deferred from 2022.
“In the U.S., the company is reaffirming its 2024 product sales outlook as it enters the second year of the commercial endemic Covid market.
“Moderna’s focus is on working with public health officials, health care providers, and pharmacies to increase vaccination coverage rates to reduce the substantial burden of COVID-19.”
To reassure investors, Moderna promised investors that a new “generation” of vaccines is coming to tackle coming strains of Covid.
Moderna touted the results of Phase 3 clinical trials of its “next generation” COVID-19 vaccine (mRNA-1283).
The company boasts a higher immune response against both new and original virus strains than its original formula.
However, the company didn’t explain why new vaccines are needed for a virus with mild symptoms that most of the world now has natural immunity against.
Clinical trials are also underway on a combination one-shot mRNA vaccine against the flu and COVID-19.
Moderna has dubbed the new injection mRNA-1083.
Data from the study is expected at some point in 2024.
The drugmaker also reaffirmed that it expects to receive approval from regulators for its respiratory syncytial virus (RSV) vaccine in time for it to be included in this fall’s vaccine campaign in the United States.
The company has expressed hope that its experimental shots—including for RSV, flu, and cancer—will compensate for dwindling COVID-19 vaccine revenue.
The promise of more profits from Moderna comes amid mounting concerns about the safety of mRNA injections, however.
While health officials maintain that Moderna’s and Pfizer’s mRNA COVID-19 vaccines are “safe and effective,” there are lingering doubts given that a significant number of vaccinated people have reported various adverse reactions.
The most common COVID-19 vaccine adverse events are those that affect the body generally, with fever, fatigue, and overall discomfort being the top three, according to the U.S. Vaccine Adverse Event Reporting System.
Cancers, heart failure, strokes, blood clots, and sudden deaths have also soared among the Covid-vaccinated.
Heart muscle inflammation (myocarditis) and inflammation of the lining outside the heart (pericarditis) have both officially been acknowledged by the Centers for Disease Control and Prevention (CDC) as known side effects of Moderna’s and Pfizer’s mRNA COVID-19 vaccines.
Nervous system disorders have also been reported, with such disorders being the third most common in the Pfizer trials, coming after general and muscle-related adverse events.
Meanwhile, data now shows that a shocking 80 percent of Covid-vaccinated pregnant women suffered miscarriages, despite assurances from the CDC that the injections were “safe” for expectant mothers.
Clinicians treating various persistent vaccine adverse reactions have said that the leading cause of such injuries is the COVID-19 spike protein.
Spike proteins exist on the surface of the SARS-CoV-2 virus that invades cells and causes disease.
The COVID-19 mRNA vaccines (such as Moderna’s and Pfizer’s) also induce the body to make spike proteins.
The cells that are exposed to the mRNA produce spike proteins and then display these proteins on their surfaces.
The immune system then attacks these spike proteins, forming an immunity against them.
As Slay News reported, the spike proteins can cause damage, including immune dysregulation, mitochondrial dysfunction, blood clotting, and vascular damage.
Multiple studies have shown that spike proteins directly bind to clotting factors in the blood, promoting both large and microclot formations.
Spike protein also damages blood vessels and is prone to forming blood clots, which can block coronary arteries, leading to heart attacks.
Additionally, CDC officials found evidence suggesting that both Pfizer’s and Moderna’s mRNA vaccines caused multiple deaths.
However, they chose to cover up the information before claiming that there was no evidence linking the vaccines to any deaths.
Follow the Link for the Article... Moderna Promises Investors 'Next Generation' Vaccines Will Surge Profits
https://worldinnovationfoundation.blogspot.com/2015/01/control-most-powerful-word-in-world-and.html
No comments:
Post a Comment